Financial News
Articles published by 89bio, Inc.
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 19, 2024
From 89bio, Inc.
Via GlobeNewswire
Tickers
ETNB
89bio Announces Appointment of Teresa Perney, Ph.D. as Chief Regulatory and Quality Officer
September 16, 2024
From 89bio, Inc.
Via GlobeNewswire
Tickers
ETNB
89bio to Participate in Upcoming Investor Conferences
August 29, 2024
From 89bio, Inc.
Via GlobeNewswire
Tickers
ETNB
89bio Appoints Francis Sarena as Chief Operating Officer
August 07, 2024
From 89bio, Inc.
Via GlobeNewswire
Tickers
ETNB
89bio to Host Key Opinion Leader Webinar on Pegozafermin’s Opportunity in Advanced MASH
May 02, 2024
From 89bio, Inc.
Via GlobeNewswire
Tickers
ETNB
89bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
February 29, 2024
From 89bio, Inc.
Via GlobeNewswire
Tickers
ETNB
89bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 06, 2024
From 89bio, Inc.
Via GlobeNewswire
Tickers
ETNB
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 05, 2024
From 89bio, Inc.
Via GlobeNewswire
Tickers
ETNB
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 19, 2023
From 89bio, Inc.
Via GlobeNewswire
Tickers
ETNB
89bio, Inc. Announces Upsized Pricing of $150.0 Million Public Offering of Common Stock and Pre-Funded Warrants
December 07, 2023
From 89bio, Inc.
Via GlobeNewswire
Tickers
ETNB
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
December 06, 2023
From 89bio, Inc.
Via GlobeNewswire
Tickers
ETNB
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.